Catching up on MRSA news (not about me)
Constant readers: I’m looking forward to having the breathing space to get back to in-depth blogging. Meanwhile, though, news is zipping by — so here’s a quick list of recent things worth reading....
View ArticleSUPERBUG interest from collegial fellow bloggers
SUPERBUG has been getting lots of positive press and reviews. (Yay us.) But a piece over the weekend was especially meaningful to me and I wanted to call it out: Flu blogger and DailyKos diarist...
View ArticleA blog reaction so perfect I want to print the whole thing…
(…but I won’t, because it’s not fair use or good blogger behavior. But I want to!) Melissa Graham of Chicago had a great corporate life — and then she re-evaluated, became a chef and caterer, and began...
View ArticleAntibiotic resistance in food — some governments pay attention
Folks, I told you Tuesday about a Congressional hearing on antibiotic resistance, featuring NIAID Director Dr. Anthony Fauci and CDC Director Dr. Thomas Frieden. Not much new was said, but it’s...
View ArticleSUPERBUG on BoingBoing!
I was thrilled to see a review of SUPERBUG on the incredibly important blog BoingBoing.net, written by (my friend and fellow Minneapolis author) Maggie Koerth-Baker. It’s so exciting to see people...
View ArticleA good start?
I happened to notice today that the WHO has posted an update to its campaign Save Lives: Clean Your Hands, which aims to get 10,000 hospitals around the world to sign on — by May 5, 2010, which is next...
View ArticleA great blog leaves the ’sphere
Constant readers: Well, the bug finally got me, or one of its close cousins did. I’ve been on the road almost nonstop, and after a book event at University of Wisconsin last week, was felled by a...
View ArticleVast increase MRSA, CA-MRSA infections among kids
I’m on the road today and have what feels like seconds between commitments, but there’s a brand new piece of research this morning that I think you folks should know about. It’s an early-online release...
View ArticleIncentives for making new antibiotics: What would it take?
Let’s play a thought experiment. Imagine that you’re a major pharmaceutical company, a public company, with shareholders that you answer to, and market analysts looking over your shoulder to see...
View ArticleBig news! This blog is moving
Constant readers: From today, SUPERBUG the blog will be switching from this site to the thoughtful, lively, chatty community at Scienceblogs. Please come visit there! Scienceblogs.com/Superbug
View Article
